MedX

MEDX Xelerator is a leading, medical-device-focused incubator and investor operating under the auspices of the Israel Innovation Authority. Current partners and collaborators include Boston Scientific, Sheba Medical Center, West Pharmaceuticals, MEDX Xelerator Partners, Consensus Business Group (CBG), Wolfson Hospital, Weill Cornell Medicine Enterprise Innovation and Ichilov Hospital.

MEDX Xelerator’s core mission is to identify and nurture high impact medical ventures that fill major unmet clinical needs with large markets to benefit patients, physicians, and investors.

MEDX Xelerator’s management team, comprised of medtech industry veterans, works closely with the incubator’s portfolio companies to consistently achieve outstanding clinical and business milestones in a capital efficient way.

Our incubator continuously scouts for innovative medical technologies in the following areas: vascular, interventional cardiology, urology, interventional oncology, medical robotics and home- and clinic-based digital solutions addressing a sound clinical need that enables remote therapy.

Our vision is to leverage the extraordinary Israeli medtech innovation ecosystem to create breakthrough solutions that genuinely fill unmet medical needs.

 

Located in Or Yehuda and Sakhnin, Israel, we are an inclusive and diverse team open to all entrepreneurs and researchers eager to advance medical science for the benefit of all.

Download the areas of interest

Our incubator is seeking medical innovations in the vascular space, interventional cardiology and other minimally invasive procedures.

Strategy

MEDX Xelerator is committed to your success during the incubator period and beyond as you develop and commercialize your medical product. Driven by the unique combination of its management, partners, collaborators, and extensive network, MEDX Xelerator provides the ultimate foundation to any aspiring medical device start up or entrepreneur.

  • R & D
  • Business Development
  • Finance
  • Regulatory
    Affairs
  • Marketing & Sales
  • Reimbursement
  • IP
  • Clinical

A deep understanding of
the R&D process

A broad set-up to support international
level R&D activities

A professional in-house dedicated laboratory
with state of the art equipment

X-Lab creative solution
creation

A global network like
no other leveraging the
network of the management team, partners, and scientific
advisory board

Business oriented
mentoring from day one

Expert advice by
industry leaders walking you through
the strategic planning process
all the way to execution

Deep understanding of global payor systems and their requirements

Seed and follow on financing

Extensive experience in
commercializing products in
global markets and launching
new products

In house counseling and
guidance for creation and
protection of IP

Direct access to leading
physicians in Israel and abroad

Ability to utilize Sheba’s
FederalWide Assurance
certification

Portfolio

  • EndoWays (March 2018) - M&A February 2021

    Disposable Robotics for the CathLab

  • Append Medical (July 2018) - Extended Series A Round July 2023

    Transseptal LAA closure system without the need for an implant

  • Exero Medical (October 2018) - Preferred seed round closed June 2024

    Early detection of postoperative anastomotic leak

  • CAPS Medical (November 2018) - Series A Closed July 2020

    Selective Minimally Invasive Treatment of Solid Tumors

  • PatenSee (April 2019) - Safe closed May 2022

    Transforming Surveillance of Dialysis Patients

  • Dimoveo Medical (July 2020) – <span>follow-on incubator investment, June 2023 </span>

    Dimoveo Medical (July 2020) – follow-on incubator investment, June 2023

    Disinfecting internal body cavities post interventional procedures

  • SwiftDuct (July 2020) - <span>follow-on incubator investment, August 2023 </span>

    SwiftDuct (July 2020) - follow-on incubator investment, August 2023

    Safe and accurate bile duct access

  • Synchrony Medical (October 2020)

    Remote Chest Physical Therapy System for Effective Airway Clearance

  • VeinWay (November 2020) - Safe closed September 2023

    Changing the Paradigm on Treating Chronic Venous Disease

  • EyeMed Technologies Ltd. (May 2024) <a href=Series A led by a strategic ophthalmology corporation closed May 2024">
  • BeWeld Medical (September 2021) Strategic Investment Agreement October 2022

    Automating Manufacturing Processes of Implanted Devices

  • NovaPulse (February 2022)

    NovaPulse (February 2022)

    Implant for Improving Blood Flow

  • Trilio Medical (November 2022)

    Trilio Medical (November 2022)

    Transcatheter Implant for Tricuspid Valve Repair

  • Pylon Medical (January 2023)

    Pylon Medical (January 2023)

    Percutaneous Trans Carotid Stenting

  • Lifecord (April 2024)

    Lifecord (April 2024)

    Transfemoral Mitral Chordal Repair Device

Xplorer
XLab

SOLUTIONS FOR UNMET NEEDS

If you identify a problem or recognize a need – let us know. We will pull in our resources, and help your idea become reality; from world class engineers through leading clinicians to market makers. Leveraging our innovation generation expertise, together we will find the best solution.

Team

  • Shai Policker

    Shai Policker

    Chief Executive Officer
  • Gal Atarot

    Gal Atarot

    Chief Technology Officer
  • Noam Taichler

    Noam Taichler

    Chief Financial Officer
  • Soli Cohen-Dahan

    Soli Cohen-Dahan

    HR and Administrative Manager
  • Orit Halevy

    Orit Halevy

    Accountant
  • Helen Shub

    Helen Shub

    Director of Finance
  • Eran Cohen

    Eran Cohen

    Director of Business Development
  • Inbar Grebler

    Inbar Grebler

    Business Development Manager
  • Danna Perlman, Adv.

    Danna Perlman, Adv.

    Director of Intellectual Property

BOARD

  • Harel Gadot

    Harel Gadot

    Chairman, CEO and Company Group Chairman MEDX Ventures
  • Shai Policker

    Shai Policker

    Chief Executive Officer, MEDX Xelerator
  • Eyal Zimlichman, MD

    Eyal Zimlichman, MD

    Deputy Director, Chief Medical Officer and Chief Innovation Officer at Sheba
  • Elad Duschak

    Elad Duschak

    Strategic Advisor to CBG, Healthcare
  • Rotem Yehuda Kakon

    Rotem Yehuda Kakon

    Strategic Investor & Portfolio Manager Advisor at CBG
  • Jonathan Goldstein

    Jonathan Goldstein

    Director, Integration and Innovation Strategy
  • Avner Halperin

    Avner Halperin

    CEO of Sheba Medical Center’s Innovation & Commercialization
  • Raphi Levy

    Raphi Levy

    Executive Director in Healthcare Banking

Advisors

  • David Bomback, MD

    David Bomback, MD

    Western Connecticut Health
  • Barry T. Katzen MD, FACR, FACC, FSIR

    Barry T. Katzen MD, FACR, FACC, FSIR

    University of Miami School of Medicine
  • Menaheam Neuman, MD

    Menaheam Neuman, MD

    Narhariya Hospital
  • Christopher Macomber, MD

    Christopher Macomber, MD

    UMass Memorial
  • Lindsay Machan, MD

    Lindsay Machan, MD

    FRCPC
  • Eyal Morag, MD

    Eyal Morag, MD

    Assuta Ashdod Medical Center
  • Chaim Lotan, M.D., F.A.C.C., F.E.S.C.

    Chaim Lotan, M.D., F.A.C.C., F.E.S.C.

    Hadassah-Hebrew University Medical Center in Jerusalem
  • Professor Charles H Knowles MBBChir, PhD, FRCS, FACCRS (hon)

    Professor Charles H Knowles MBBChir, PhD, FRCS, FACCRS (hon)

  • Dave Knapp

    Dave Knapp

    Vice President, Corporate Research, Boston Scientific Corporation

Partners

  • Boston Scientific

    Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years,we advance science for life…Read More »

  • CBG

    CBG is a British investment group with an international investment portfolio in various areas such as pharma, biotech, MedTech, cleantech, real estate and more. CBG’s investment approach driven by an in – depth analysis of trends…Read More »

  • MEDX Ventures Group

    MEDX Ventures Group, founded in 2010, is an investment and management firm with offices in Israel, USA and Europe. The company believes in active management (vs. passive investment) and is focused on medical ventures and technologies…Read More »

  • The Chaim Sheba Academic Medical Center at Tel Hashomer

    The Sheba Medical Center at Tel Hashomer is a university-affiliated tertiary referral hospital that serves as Israel’s national medical center in many fields. Adjacent to Tel Aviv, it is the most comprehensive medical center in the Middle East, renowned for…Read More »

  • Intellectual Ventures

    Intellectual Ventures is a global inventions company. Founded in 2000, we provide the world’s most innovative companies with access to valuable patents and invention related services while creating a wide range of technology-focused partnerships and wholly new companies.Read More »

Roadmap for Entrepreneurs

Do you have an idea for a medical device related to minimally invasive procedures,
medical robotics, medical implants, or digital health?

Here is what to do and an estimated timeline, assuming all approvals are granted along the way.

Click or roll over the stages below for more details:
Send an email 2 weeks icon icon
Meet with us 4 weeks icon icon
Begin due diligence 2-3 months icon icon
Investment committee 1 month icon icon
Israel Innovation Authority submission 2 months icon icon
Join MEDX Xelerator icon icon
Send an email 2 weeks icon icon
Meet with us 4 weeks icon icon
Begin due diligence 2-3 months icon icon
Investment committee 1 month icon icon
Israel Innovation Authority submission 2 months icon icon
Join MEDX Xelerator icon icon

Send us an email to [email protected] with a presentation and a one-page explanation about your idea.
Please make sure you address the following topics:
1. Team
2. The problem you are solving
3. Your solution and technology
4. Business model
5. Market size (patients/procedures/$$$)
6. Intellectual property
7. Regulatory strategy
8. Development plan (timeline & budget, first two years)

We will invite you to a meeting with the MEDX Xelerator team in our offices, where we could hear more and discuss the project.

We will sign a “confidential disclosure agreement” (CDA) and begin the due diligence process.

Once due diligence is complete, we will present the project to MEDX Xelerator’s investment committee.

We will submit the project to the Israel Innovation Authority.

Once the project is approved by the Israel Innovation Authority, you will join MEDX Xelerator.

Send us an email to [email protected] with a presentation and a one-page explanation about your idea.
Please make sure you address the following topics:
1. Team
2. The problem you are solving
3. Your solution and technology
4. Business model
5. Market size (patients/procedures/$$$)
6. Intellectual property
7. Regulatory strategy
8. Development plan (timeline & budget, first two years)

We will invite you to a meeting with the MEDX Xelerator team in our offices, where we could hear more and discuss the project.

We will sign a “confidential disclosure agreement” (CDA) and begin the due diligence process.

Once due diligence is complete, we will present the project to MEDX Xelerator’s investment committee.

We will submit the project to the Israel Innovation Authority.

Once the project is approved by the Israel Innovation Authority, you will join MEDX Xelerator.

At MEDX Xelerator you will benefit from:

A. Ongoing support from the MEDX Xelerator team and its partners
B. Over $800,000 for a period of 2 years and up to $1.1 million for a period of 3 years

 

Careers

CONTACT US

    • We want to hear from you! Upload Materials

    • I agree to receive information and updates by mail from MEDX Xelerator

    P.O. Box 619
    8 Ariel Sharon St.
    Or Yehuda 6037606, Israel

    Office: +972-3-939-0888 [email protected] www.medxelerator.com
    Want more info? sign up to our newlsetter!
    LinkedIn Medx
    waze quick link

    This website uses cookies

    We use cookies to enhance your experience on our site. Visit our Privacy Policy and Terms and Conditions of Use to learn more. By using our site, you agree to our use of cookies.

    Agree | Learn More
    Subscribe to Newsletter